EC Number | Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|---|
3.4.21.39 | cytoplasmic vesicle | - |
Mus musculus | 31410 | - |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.4.21.39 | Mus musculus | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
3.4.21.39 | heart | interstitial fluid from left ventricle | Mus musculus | - |
3.4.21.39 | mast cell | - |
Mus musculus | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.4.21.39 | angiotensin I + H2O | - |
Mus musculus | angiotensin II + ? | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
3.4.21.39 | mast cell chymase | - |
Mus musculus |
EC Number | Organism | Comment | Expression |
---|---|---|---|
3.4.21.39 | Mus musculus | chronic angiotensin I-converting enzyme inhibition causes a marked bradykinin/B2 receptor-mediated increase in left ventricle interstitial fluid chymase activity | up |
EC Number | General Information | Comment | Organism |
---|---|---|---|
3.4.21.39 | malfunction | chymase inhibition improves LV function and decreases adverse cardiac remodeling after myocardial infarction | Mus musculus |